• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围产期HIV感染早期长期抗逆转录病毒治疗后完整非诱导前病毒的缺乏

Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection.

作者信息

Rainwater-Lovett Kaitlin, Ziemniak Carrie, Watson Douglas, Luzuriaga Katherine, Siberry George, Petru Ann, Chen YaHui, Uprety Priyanka, McManus Margaret, Ho Ya-Chi, Lamers Susanna L, Persaud Deborah

机构信息

Department of Pediatrics-Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.

Department of Pediatrics, University of Maryland, Baltimore, MD, United States of America.

出版信息

PLoS One. 2017 Feb 8;12(2):e0170548. doi: 10.1371/journal.pone.0170548. eCollection 2017.

DOI:10.1371/journal.pone.0170548
PMID:28178277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5298215/
Abstract

The latent reservoir is a major barrier to HIV eradication. Reservoir size is emerging as an important biomarker to assess the likelihood of HIV remission in the absence of antiretroviral therapy (ART) and may be reduced by earlier initiation of ART that restricts HIV spread into CD4+ T cells. Reservoir size is traditionally measured with a quantitative viral outgrowth assay (QVOA) that induces replication-competent HIV production through in vitro stimulation of resting CD4+ T cells. However, the recent identification of replication-intact, non-induced proviral genomes (NIPG) suggests the QVOA significantly underestimates (by 62-fold) latent reservoir size in chronically-infected adults. Whether formation and persistence of Intact, NIPG is thwarted by early ART initiation and long-term virologic suppression in perinatal infection is unclear. Here, we show that the latent reservoir in 11 early treated, long-term suppressed perinatally infected children and adolescents was not inducible by QVOA and dominated by defective, NIPG. Single genome analysis of 164 NIPG from 232 million cultured resting CD4+ T cells revealed no replication-intact, near-full length sequences. Forty-three (26%) NIPG contained APOBEC3G-mediated hypermutation, 115 (70%) NIPG contained large internal deletions, one NIPG contained nonsense mutations and indels, and 5 (3%) NIPG were assigned as "Not Evaluable" due to multiple failed sequencing attempts that precluded further classification. The lack of replication competent inducible provirus and intact NIPG in this cohort indicate early, long-term ART of perinatal infection leads to marked diminution of replication-competent HIV-1 reservoirs, creating a favorable state towards interventions aimed at virologic remission.

摘要

潜伏病毒库是根除艾滋病病毒的主要障碍。病毒库大小正成为一种重要的生物标志物,用于评估在不进行抗逆转录病毒疗法(ART)的情况下艾滋病病毒缓解的可能性,并且早期开始ART限制艾滋病病毒传播到CD4+T细胞中可能会使其减小。传统上,病毒库大小是通过定量病毒增殖测定(QVOA)来测量的,该测定通过体外刺激静止的CD4+T细胞诱导具有复制能力的艾滋病病毒产生。然而,最近对复制完整、未诱导的前病毒基因组(NIPG)的鉴定表明,QVOA显著低估了(62倍)慢性感染成年人中的潜伏病毒库大小。围产期感染中完整的NIPG的形成和持续是否会因早期ART启动和长期病毒学抑制而受阻尚不清楚。在这里,我们表明,11名早期接受治疗、长期病毒受到抑制的围产期感染儿童和青少年中的潜伏病毒库不能被QVOA诱导,且以有缺陷的NIPG为主。对来自2.32亿个培养的静止CD4+T细胞的164个NIPG进行单基因组分析,未发现复制完整、接近全长的序列。43个(26%)NIPG包含载脂蛋白B mRNA编辑酶催化多肽样3G(APOBEC3G)介导的超突变,115个(70%)NIPG包含大的内部缺失,1个NIPG包含无义突变和插入缺失,5个(3%)NIPG由于多次测序失败而无法进一步分类,被指定为“不可评估”。该队列中缺乏具有复制能力的可诱导前病毒和完整的NIPG表明,围产期感染的早期长期ART导致具有复制能力的艾滋病病毒-1病毒库显著减少,为旨在实现病毒学缓解的干预措施创造了有利条件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd4/5298215/4f76a4d98d47/pone.0170548.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd4/5298215/c3d327c81b3c/pone.0170548.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd4/5298215/b38c282e7b65/pone.0170548.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd4/5298215/98badeb9cf77/pone.0170548.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd4/5298215/4f76a4d98d47/pone.0170548.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd4/5298215/c3d327c81b3c/pone.0170548.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd4/5298215/b38c282e7b65/pone.0170548.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd4/5298215/98badeb9cf77/pone.0170548.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd4/5298215/4f76a4d98d47/pone.0170548.g004.jpg

相似文献

1
Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection.围产期HIV感染早期长期抗逆转录病毒治疗后完整非诱导前病毒的缺乏
PLoS One. 2017 Feb 8;12(2):e0170548. doi: 10.1371/journal.pone.0170548. eCollection 2017.
2
Intact HIV Proviruses Persist in Children Seven to Nine Years after Initiation of Antiretroviral Therapy in the First Year of Life.在生命的第一年开始抗逆转录病毒治疗后,完整的 HIV 前病毒在儿童七到九年内持续存在。
J Virol. 2020 Jan 31;94(4). doi: 10.1128/JVI.01519-19.
3
Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir.测量复制型 HIV-1:定义潜伏库所面临的挑战与进展。
Retrovirology. 2018 Feb 13;15(1):21. doi: 10.1186/s12977-018-0404-7.
4
A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.感染儿童静止CD4(+) T淋巴细胞中存在稳定的HIV-1潜伏储存库。
J Clin Invest. 2000 Apr;105(7):995-1003. doi: 10.1172/JCI9006.
5
Identification of Genetically Intact HIV-1 Proviruses in Specific CD4 T Cells from Effectively Treated Participants.在有效治疗的参与者的特定 CD4 T 细胞中鉴定遗传完整的 HIV-1 前病毒。
Cell Rep. 2017 Oct 17;21(3):813-822. doi: 10.1016/j.celrep.2017.09.081.
6
Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure.潜伏的人类免疫缺陷病毒 1 型前病毒的低诱导率是治愈的主要障碍。
J Infect Dis. 2021 Feb 15;223(12 Suppl 2):13-21. doi: 10.1093/infdis/jiaa649.
7
Detection of Inducible Replication-Competent HIV-1 Subtype C Provirus Despite Long-Term Antiretroviral Treatment in Perinatally Infected Adolescents in Botswana.尽管在博茨瓦纳接受了长期抗逆转录病毒治疗,但在围生期感染的青少年中仍能检测到诱导复制型有复制能力的 HIV-1 亚型 C 前病毒。
AIDS Res Hum Retroviruses. 2021 Jan;37(1):16-23. doi: 10.1089/AID.2020.0097. Epub 2020 Oct 19.
8
Improved assays to measure and characterize the inducible HIV reservoir.改进的检测方法,用于测量和描述诱导型 HIV 储库。
EBioMedicine. 2018 Oct;36:113-121. doi: 10.1016/j.ebiom.2018.09.036. Epub 2018 Oct 11.
9
Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy.抗逆转录病毒治疗时完整 HIV-1 前病毒 DNA 的选择性衰减。
J Infect Dis. 2021 Feb 3;223(2):225-233. doi: 10.1093/infdis/jiaa532.
10
Sequence Evaluation and Comparative Analysis of Novel Assays for Intact Proviral HIV-1 DNA.新型完整前病毒 HIV-1 DNA 检测方法的序列评估与比较分析。
J Virol. 2021 Feb 24;95(6). doi: 10.1128/JVI.01986-20.

引用本文的文献

1
Human models that inform antiretroviral therapy-free remission with perinatally acquired HIV infection.为围产期获得性HIV感染的无抗逆转录病毒治疗缓解提供信息的人体模型。
Curr Opin HIV AIDS. 2025 May 1;20(3):249-256. doi: 10.1097/COH.0000000000000918. Epub 2025 Mar 19.
2
Higher HIV-1 Env gp120-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity Is Associated with Lower Levels of Defective HIV-1 Provirus.更高的 HIV-1 包膜 gp120 特异性抗体依赖的细胞细胞毒性 (ADCC) 活性与更低水平的缺陷 HIV-1 前病毒相关。
Viruses. 2023 Oct 6;15(10):2055. doi: 10.3390/v15102055.
3
Advances in Pediatric HIV-1 Cure Therapies and Reservoir Assays.

本文引用的文献

1
Defective proviruses rapidly accumulate during acute HIV-1 infection.在急性HIV-1感染期间,缺陷型前病毒会迅速积累。
Nat Med. 2016 Sep;22(9):1043-9. doi: 10.1038/nm.4156. Epub 2016 Aug 8.
2
Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy.在接受联合抗逆转录病毒治疗的HIV感染患者中,有缺陷的HIV-1前病毒产生新的蛋白质编码RNA种类。
Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):8783-8. doi: 10.1073/pnas.1609057113. Epub 2016 Jul 18.
3
Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants.
儿科 HIV-1 治愈疗法和储存库检测的进展。
Viruses. 2022 Nov 23;14(12):2608. doi: 10.3390/v14122608.
4
HIV-1 reservoir evolution in infants infected with clade C from Mozambique.莫桑比克 C 型 clade 感染婴儿的 HIV-1 储存库演变。
Int J Infect Dis. 2023 Feb;127:129-136. doi: 10.1016/j.ijid.2022.11.042. Epub 2022 Dec 5.
5
Influence of Combination Antiretroviral Therapy on HIV-1 Serological Responses and Their Implications: A Systematic Review and Meta-Analysis.联合抗逆转录病毒疗法对 HIV-1 血清学反应的影响及其意义:系统评价和荟萃分析。
Front Immunol. 2022 Mar 30;13:844023. doi: 10.3389/fimmu.2022.844023. eCollection 2022.
6
Measuring Proviral HIV-1 DNA: Hurdles and Improvements to an Assay Monitoring Integration Events Utilising Human Repeat Sequences.测量前病毒HIV-1 DNA:利用人类重复序列监测整合事件的检测方法面临的障碍与改进
Life (Basel). 2021 Dec 16;11(12):1410. doi: 10.3390/life11121410.
7
Insights from Clonal Expansion and HIV Persistence in Perinatal Infections.围产期感染中克隆扩增和 HIV 持续存在的相关研究进展
mBio. 2021 Aug 31;12(4):e0098321. doi: 10.1128/mBio.00983-21. Epub 2021 Aug 24.
8
HIV-1 Persistence in Children during Suppressive ART.HIV-1 持续性感染在接受抑制性 ART 治疗的儿童中。
Viruses. 2021 Jun 12;13(6):1134. doi: 10.3390/v13061134.
9
The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV.HIV-1 抗体反应:垂直感染 HIV 的儿童中病毒储存库的足迹。
Lancet HIV. 2020 May;7(5):e359-e365. doi: 10.1016/S2352-3018(20)30100-4.
10
Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure.儿科 HIV:免疫治疗实现病毒缓解和功能性治愈的潜力。
Curr HIV/AIDS Rep. 2020 Jun;17(3):237-248. doi: 10.1007/s11904-020-00495-1.
HIV-1感染婴儿早期联合抗逆转录病毒治疗期间细胞相关HIV-1 DNA和RNA的衰减动力学
Clin Infect Dis. 2015 Dec 15;61(12):1862-70. doi: 10.1093/cid/civ688. Epub 2015 Aug 13.
4
HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days--Implications for HIV Remission.治疗中断后潜伏的HIV平均每5 - 8天重新激活一次——对HIV缓解的影响。
PLoS Pathog. 2015 Jul 2;11(7):e1005000. doi: 10.1371/journal.ppat.1005000. eCollection 2015 Jul.
5
Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial: a retrospective analysis.作为儿童早期抗逆转录病毒治疗(CHER)试验的一部分,对婴儿早期开始抗逆转录病毒治疗的儿童进行常规HIV抗体检测的反应性:一项回顾性分析。
Lancet Infect Dis. 2015 Jul;15(7):803-9. doi: 10.1016/S1473-3099(15)00087-0. Epub 2015 Jun 1.
6
HIV reservoirs as obstacles and opportunities for an HIV cure.HIV 储库——HIV 治愈的障碍与机遇。
Nat Immunol. 2015 Jun;16(6):584-9. doi: 10.1038/ni.3152.
7
Viremic relapse after HIV-1 remission in a perinatally infected child.一名围产期感染儿童HIV-1缓解后出现病毒血症复发。
N Engl J Med. 2015 Feb 19;372(8):786-8. doi: 10.1056/NEJMc1413931.
8
Early Antiretroviral Therapy in South African Children Reduces HIV-1-Infected Cells and Cell-Associated HIV-1 RNA in Blood Mononuclear Cells.南非儿童早期抗逆转录病毒疗法可减少血液单核细胞中HIV-1感染细胞及细胞相关HIV-1 RNA
J Infect Dis. 2015 Jul 1;212(1):39-43. doi: 10.1093/infdis/jiu827. Epub 2014 Dec 23.
9
Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation.在急性HIV感染早期启动抗逆转录病毒治疗可保留黏膜Th17功能并逆转HIV相关的免疫激活。
PLoS Pathog. 2014 Dec 11;10(12):e1004543. doi: 10.1371/journal.ppat.1004543. eCollection 2014 Dec.
10
How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?急性感染中抗逆转录病毒疗法开始的时机如何影响艾滋病毒储存库?
Curr Opin HIV AIDS. 2015 Jan;10(1):18-28. doi: 10.1097/COH.0000000000000122.